MIM
SNCE

MetLife Investment Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

MetLife Investment Management’s Portfolio SNCE Stock Details SNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,924
Closed -$77.4K – 2856
2022
Q2 		$77.4K Buy
+1,924
New +$141K ﹤0.01% 2770

Other funds holding SNCE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
GCM
Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MetLife Investment Management's SNCE Position: Q3 2022 in Review

MetLife Investment Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 1,924 shares — an estimated $77.4K sold.

MetLife Investment Management first reported a position in SNCE in Q2 2022 and held it in 1 quarter. The position peaked at $77.4K in Q2 2022. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • MetLife Investment Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • MetLife Investment Management sold 1,924 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $77.4K.
  • MetLife Investment Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • MetLife Investment Management's Science 37 Holdings, Inc. Common Stock position peaked at $77.4K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.